fda warning letters glp-1 compounding september 26 2025 Issues to 30 Telehealth Companies Over Misleading Compounded RA Marketing U.S. - FDA issued 25

Deeper pigmentation and old tan can take longer, and results always vary from person to person depending on skin type, sun exposure, and daily care routine

Osteogenic effect of a gastric pentadecapeptide BPC 157, on the healing of segmental bone defect in rabbits

Researchers have warned that many women taking glucagon-like peptide-1 (GLP-1) receptor agonists may be unaware of the associated risks of unplanned pregnancy, or potential foetal risks linked to the medications

54.5%) in the year following their PMOS diagnosis compared to non-initiators

These medications are administered to regulate blood glucose levels and promote weight loss through various mechanisms of action

Growth hormone secretagogues are banned by most athletic organizations including WADA